Kelyniam Global, Inc.
KLYG - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.01M
Close$
$-0.03
125.5% downside
Current Fair Value
125.5% downsideOvervalued by 125.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.01 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | -0.1 |
| Outstanding Shares | 50,623,430 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -23.26 |
|---|---|
| PEG | 7.23 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Kelyniam Global, Inc.
9 employees
CEO: Ross Bjella
Kelyniam Global, Inc. operates as a medical device manufacturer, providing specialized solutions for patients. The company creates custom prosthetics using computer-aided design (CAD) and manufacturing (CAM) processes, employing advanced...